Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Can proton pump inhibitors cause intestinal inflammation in children?

  • Kang, Ben (Department of Pediatrics, School of Medicine, Kyungpook National University)
  • 투고 : 2019.08.25
  • 심사 : 2019.10.02
  • 발행 : 2019.10.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Gonzalez Ayerbe JI, Hauser B, Salvatore S, Vandenplas Y. Diagnosis and management of gastroesophageal reflux disease in infants and children: from guidelines to clinical practice. Pediatr Gastroenterol Hepatol Nutr 2019;22:107-21. https://doi.org/10.5223/pghn.2019.22.2.107
  2. Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:516-54. https://doi.org/10.1097/MPG.0000000000001889
  3. Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil 2018;24:182-96. https://doi.org/10.5056/jnm18001
  4. Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf 2018;10:2042098618809927.
  5. Nylund CM, Eide M, Gorman GH. Association of Clostridium difficile infections with acid suppression medications in children. J Pediatr 2014;165:979-84.e1. https://doi.org/10.1016/j.jpeds.2014.06.062
  6. Jeong SJ. The role of fecal calprotectin in pediatric disease. Korean J Pediatr 2019;62:287-91. https://doi.org/10.3345/kjp.2019.00059
  7. Kim S, Lee NM, Yun SW, Chae SA, Lim IS, Choi ES, et al. Influence of proton pump inhibitor therapy on intestinal inflammation assessed by fecal calprotectin in pediatric patients. Korean J Pediatr 2019;62:400-4. https://doi.org/10.3345/kjp.2019.00115
  8. Poullis A, Foster R, Mendall MA, Shreeve D, Wiener K. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity. Eur J Gastroenterol Hepatol 2003;15:573-4. https://doi.org/10.1097/01.meg.0000059108.41030.23
  9. Lundgren D, Eklof V, Palmqvist R, Hultdin J, Karling P. Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scand J Gastroenterol 2019;54:152-7. https://doi.org/10.1080/00365521.2019.1566493
  10. Yang A, Kang B, Choe JY, Kim HS, Kim K, Choe YH. Prevalence and epidemiological characteristics of endoscopically proven reflux esophagitis in children in Korea. Pediatr Gastroenterol Hepatol Nutr 2017;20:160-6. https://doi.org/10.5223/pghn.2017.20.3.160